DE4432053A1 - Use of Listeria bacteriophage coded lysine - Google Patents

Use of Listeria bacteriophage coded lysine

Info

Publication number
DE4432053A1
DE4432053A1 DE19944432053 DE4432053A DE4432053A1 DE 4432053 A1 DE4432053 A1 DE 4432053A1 DE 19944432053 DE19944432053 DE 19944432053 DE 4432053 A DE4432053 A DE 4432053A DE 4432053 A1 DE4432053 A1 DE 4432053A1
Authority
DE
Germany
Prior art keywords
lysine
listeria
proteins
coded
rna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19944432053
Other languages
German (de)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SCHERER SIEGFRIED UNIV PROF DR
Original Assignee
SCHERER SIEGFRIED UNIV PROF DR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SCHERER SIEGFRIED UNIV PROF DR filed Critical SCHERER SIEGFRIED UNIV PROF DR
Priority to DE19944432053 priority Critical patent/DE4432053A1/en
Priority to DE59510532T priority patent/DE59510532D1/en
Priority to AU35227/95A priority patent/AU3522795A/en
Priority to EP95932002A priority patent/EP0781349B1/en
Priority to PCT/EP1995/003512 priority patent/WO1996007756A1/en
Publication of DE4432053A1 publication Critical patent/DE4432053A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • C12P13/08Lysine; Diaminopimelic acid; Threonine; Valine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/005Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor after treatment of microbial biomass not covered by C12N1/02 - C12N1/08
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Sustainable Development (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Listeria bacteriophage coded lysine is used to solubilise bacterial cell suspensions of the Listeria genus, by adding a small amt. of the purified lysine prepn. to the cell suspension for effective prepn. and purificn. of cellular components such as chromosomal DNA, plasmids, RNA and proteins.

Description

Gebiet der ErfindungField of the Invention

Zur Untersuchung der zellulären Bestandteile von Listeria (z. B. chromosomale DNS, Plasmide, RNS, Proteine, Lipide, Metabolite) müssen die Zellen möglichst schnell und schonend aufgeschlossen (zerstört) werden können, um die Integrität und Funktionalität der isolierten Bestandteile und Makromoleküle zu gewährleisten.To examine the cellular components of Listeria (e.g. chromosomal DNA, plasmids, RNA, proteins, lipids, metabolites) must Cells are opened (destroyed) as quickly and gently as possible can to the integrity and functionality of the isolated components and to ensure macromolecules.

Stand der TechnikState of the art

Bisher sind 4 Methoden zur Gewinnung von Nukleinsäuren oder Proteinen aus Listeria Zellen verfügbar: (1) Die enzymatische Zerstörung der Zellwand durch Lysozym (Zeitschrift "Infection and Immunity", 1984, Jahrgang 44, S. 157-161) ist sehr langsam und ineffizient, dadurch nicht geeignet für die Darstellung von m-RNS und zellwandassoziierten Proteinen. (2) Die Kombination aus enzymatischer und chemischer Zerstörung der Zellwand (Zeitschrift "Letter. in Applied Microbiology", 1989, Jahrgang 8, S. 151-156; Zeitschrift "Journal of Bacteriology", 1994, Jahrgang 176, S. 3040-3048) ist ebenfalls wenig effizient und weiterhin recht aufwendig in der Durchführung. Außerdem werden Proteine irreversibel denaturiert, was ein wesentlicher Nachteil ist. (3) Der mechanisch-physikalische Zellaufschluß mittels Ultraschall (Zeitschrift "Medical Microbiology and Immunology", 1992, Jahrgang 181, Seiten 283-291) oder (4) Überdruck-Entspannung (z. B. "French-Press System") ermöglicht nur die ebenfalls wenig ergiebige Isolierung zellulärer Proteine, während Nukleinsäuren zerstört werden und Zellwand-gebundene Proteine nicht freigesetzt werden können.So far there are 4 methods for obtaining nucleic acids or proteins Listeria cells available: (1) The enzymatic destruction of the cell wall by lysozyme (magazine "Infection and Immunity", 1984, year 44, p. 157-161) is very slow and inefficient, therefore not suitable for the Representation of m-RNA and cell wall-associated proteins. (2) The Combination of enzymatic and chemical destruction of the cell wall (Journal "Letter. In Applied Microbiology", 1989, Volume 8, pp. 151-156; Journal of Bacteriology, 1994, year 176, pp. 3040-3048) is also not very efficient and is still quite complex to use Execution. In addition, proteins are irreversibly denatured, which is a major disadvantage is. (3) The mechanical-physical cell disruption using ultrasound (journal "Medical Microbiology and Immunology", 1992, year 181, pages 283-291) or (4) relief from overpressure (e.g. "French-Press System") only enables the less productive one Isolation of cellular proteins while nucleic acids are being destroyed and Proteins that are bound to the cell wall cannot be released.

Das im folgenden beschriebene Verfahren weist die genannten Nachteile nicht auf, ist sehr einfach und schnell durchzuführen, und eignet sich zur effizienten Isolierung aller Nukleinsäuren und Proteine. The method described below does not have the disadvantages mentioned is very easy and quick to carry out, and is suitable for efficient isolation of all nucleic acids and proteins.  

Beschreibung der ErfindungDescription of the invention

Bisher wurden zahlreiche Bakteriophagen für die Gattung Listeria isoliert und beschrieben, darunter viele eigene Isolate aus diesem Labor. Als finales Produkt der Expression der sog. "späten Gene" während der Phageninfektion wird ein zellwandlytisches Enzym (Phagen-Lysin) gebildet, welches die Freisetzung der neugebildeten Viren aus den Zellen ermöglicht. Diese Lysine spalten spezifisch die Peptidbindungen zwischen den einzelnen Murein-Schichten der Listeria-Zellwände (L-Alanin-Amidasen, D-Glutamin Amidasen).So far, numerous bacteriophages have been isolated for the genus Listeria and described, including many of their own isolates from this laboratory. As final product of the expression of the so-called "late genes" during the Phage infection a cell wall lytic enzyme (phage lysine) is formed, which enables the release of the newly formed viruses from the cells. These lysines specifically cleave the peptide bonds between them Murein layers of the Listeria cell walls (L-alanine amidases, D-glutamine Amidases).

Durch externe Zugabe gereinigter Lysin-Präparationen von den Listeriaphagen A511 oder A118 zu Zellsuspensionen von Listeria wird eine schnelle (2-6 min.) und vollständige (95-100%) Zellwand-Hydrolyse erreicht. Dabei werden neben zellinneren Bestandteilen (chromosomale DNS, Plasmide, RNS, Proteine, etc.) auch sämtliche Zellwand-assoziierten (nicht-kovalent gebundenen) Proteine freigesetzt. Alle Makromoleküle liegen anschließend nativ vor, sind aktiv und keiner chemischen Schädigung ausgesetzt. Versuche in diesem Labor ergaben eine etwa 50-80% bessere Effizienz in Bezug auf die Isolierung von Nukleinsäuren, neben einer Zeitersparnis von mehreren Stunden pro Ansatz.By externally adding purified lysine preparations from the Listeriaphagen A511 or A118 for cell suspensions from Listeria becomes one rapid (2-6 min.) and complete (95-100%) cell wall hydrolysis achieved. In addition to components inside the cell (chromosomal DNA, plasmids, RNA, proteins, etc.) also all cell wall-associated (non-covalent bound) proteins released. All macromolecules are then lying native, active and not exposed to chemical damage. Trials in this laboratory showed approximately 50-80% better efficiency in Regarding the isolation of nucleic acids, in addition to a time saving of several hours per approach.

Diese Methode und deren molekularbiologische Grundlagen wurde noch nirgendwo publiziert.This method and its molecular biological basis was still published anywhere.

Herstellung und Lagerung der LysineProduction and storage of the lysines

Die biochemische Isolierung der o.a. Phagen-Lysine wurde bis zu Reinheit durchgeführt. Zusätzlich zur Aufreinigung der Enzyme aus Phagen-Lysaten wurden die Lysine aus rekombinanten Stämmen von Escherichia coli gewonnen, welche die entsprechenden Gene aus den Listeriaphagen A511 oder A118 auf einem Expressionsplasmid tragen. Hierbei können die Zellen in hoher Ausbeute (bis zu 20% des Gesamt-Proteins) Lysine produzieren. Diese rekombinanten Enzyme lassen sich leichter isolieren und reinigen, und weisen dieselbe Spezifität bei keiner nachweisbaren Fremdaktivität auf. Die gereinigten Amidasen werden in einem wäßrigen Puffersystem bei tiefen Temperaturen (-30°C) aufbewahrt und sind mindestens 6 Monate stabil.The biochemical isolation of the above Phage lysine was up to purity carried out. In addition to purifying the enzymes from phage lysates the lysines were obtained from recombinant strains of Escherichia coli, which the corresponding genes from Listeriaphagen A511 or A118 carry an expression plasmid. Here, the cells can be high Yield (up to 20% of the total protein) produce lysines. These recombinant enzymes are easier to isolate and purify, and have the same specificity with no detectable external activity. The purified amidases are in an aqueous buffer system at depth Temperatures (-30 ° C) are kept and are stable for at least 6 months.

Gewerbliche NutzungCommercial use

Produktion, Reinigung und Verkauf von Listeriaphagen-Lysin Präparaten an Forschungsinstitute o. ä. Es gibt keine vergleichbare Alternative für diese Methode des schnellen und schonenden Zellaufschlusses.Production, cleaning and sale of Listeriaphagen-Lysin preparations Research institutes or similar. There is no comparable alternative for this  Method of fast and gentle cell disruption.

AusführungsbeispielEmbodiment

Die Darstellung des zellulären Expressionsstatus auf Transkriptionsebene verlangt die möglichst schnelle und schonende Isolierung der momentan in der Zelle vorliegenden, zum Teil außerordentlich instabilen mRNS-Moleküle.The representation of the cellular expression status at the transcription level demands the quickest possible and gentle isolation of the current in mRNA molecules present in the cell, some of which are extremely unstable.

Zur Isolierung von m-RNS aus Kulturen von Listeria inonocytogenes werden die Zellen in kleinen Volumina (ca. 1-5 ml) durch Zentrifugation konzentriert, kurz in einem Trockeneis-Ethanol Gemisch eingefroren (ca. 1-5 min.), und in 1/10 Volumen eines geeigneten Puffers (z. B.: Tris-HCl, 20 mM, pH 8,0) resuspendiert. Nach Zugabe einer geringen Menge des rekombinanten Lysins (A118 Amidase, in 20 mM Tris-HCl, PH 7,3, 20 mM NaCl, 0,1% Triton X100) wird etwa 2-5 Minuten bei Raumtemperatur inkubiert, bis die trübe Suspension fast völlig klar geworden ist. Nach Deproteinierung der Suspension (mit Phenol:Chloroform:Isoamylalkohol, 125 : 24 : 1 (V/V), pH 4,2) kann die RNS durch ethanolische Fällung direkt gewonnen werden. Reste von DNS können gegebenenfalls durch hydrolytische Spaltung mit DNAse entfernt werden. Die nun völlig reine RNS steht für weitere Untersuchungen zur Verfügung.For the isolation of m-RNA from cultures of Listeria inonocytogenes cells in small volumes (approx. 1-5 ml) by centrifugation concentrated, briefly frozen in a dry ice-ethanol mixture (approx. 1-5 min.), and in 1/10 volume of a suitable buffer (e.g. Tris-HCl, 20 mM, pH 8.0) resuspended. After adding a small amount of the recombinant Lysine (A118 amidase, in 20mM Tris-HCl, pH 7.3, 20mM NaCl, 0.1% Triton X100) is incubated for about 2-5 minutes at room temperature until the cloudy Suspension has become almost completely clear. After deproteination of the Suspension (with phenol: chloroform: isoamyl alcohol, 125: 24: 1 (v / v), pH 4.2) the RNA can be obtained directly by ethanolic precipitation. Remnants of DNA can optionally be removed by hydrolytic cleavage with DNAse will. The now completely pure RNA is available for further examinations Available.

Claims (2)

Verwendung von Listeriabakteriophagen-kodierten Lysinen zum Aufschluß von Bakteriensuspensionen der Gattung Listeria, mit dem Ziel der effizienten und schonenden Darstellung und Reinigung zellulärer Komponenten wie chromosomaler DNS, Plasmiden, RNS und Proteinen. Das Verfahren ist dadurch gekennzeichnet, daß geringe Mengen gereinigter Lysin-Präparationen der Zellsuspension zugesetzt werden.Use of Listeria bacteriophage-encoded lysines for the digestion of bacterial suspensions of the genus Listeria, with the aim of the efficient and gentle presentation and purification of cellular components such as chromosomal DNA, plasmids, RNA and proteins. The method is characterized in that small amounts of purified lysine preparations are added to the cell suspension. Produktion, Aufreinigung und Inverkehrbringung der Lysine. Die Produktion geschieht mit rekombinanten Stämmen von Escherichia coli K-12, welche das/die Gen(e) für die Lysine auf einem Expressionsplasmid tragen.Production, purification and marketing of the lysine. The production happens with recombinant strains of Escherichia coli K-12, which carry the gene (s) for the lysines on an expression plasmid.
DE19944432053 1994-09-09 1994-09-09 Use of Listeria bacteriophage coded lysine Withdrawn DE4432053A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
DE19944432053 DE4432053A1 (en) 1994-09-09 1994-09-09 Use of Listeria bacteriophage coded lysine
DE59510532T DE59510532D1 (en) 1994-09-09 1995-09-07 DIGESTION OF BACTERIAL CELLS BY PHAGENLYSINE
AU35227/95A AU3522795A (en) 1994-09-09 1995-09-07 Decomposition of bacteria cells by phage lysins
EP95932002A EP0781349B1 (en) 1994-09-09 1995-09-07 Decomposition of bacteria cells by phage lysins
PCT/EP1995/003512 WO1996007756A1 (en) 1994-09-09 1995-09-07 Decomposition of bacteria cells by phage lysins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19944432053 DE4432053A1 (en) 1994-09-09 1994-09-09 Use of Listeria bacteriophage coded lysine

Publications (1)

Publication Number Publication Date
DE4432053A1 true DE4432053A1 (en) 1996-03-14

Family

ID=6527749

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19944432053 Withdrawn DE4432053A1 (en) 1994-09-09 1994-09-09 Use of Listeria bacteriophage coded lysine

Country Status (1)

Country Link
DE (1) DE4432053A1 (en)

Similar Documents

Publication Publication Date Title
DE69738581T2 (en) HUMAN DNASE I HYPERACTIVE VARIANTS
EP0765335B1 (en) Universal process for isolating and purifying nucleic acids from extremely small amounts of highly contaminated various starting materials
DE2535554C2 (en) Biological process
DE3687266T2 (en) BACTERIAL ENZYMES AND METHODS FOR THEIR PRODUCTION.
CH642396A5 (en) METHOD FOR PRODUCING HYBRID BACTERIA.
CH659480A5 (en) METHOD FOR EFFECTIVELY PROTEIN PRODUCTION AND RECOMBINANT DNA MOLECULE.
EP1723233B1 (en) Method for enriching and/or separating prokaryotic dna using a protein that specifically bonds to unmethylated dna containing cpg-motives
EP0027662A1 (en) Eucaryotic cells and eucaryotic protoplasts with an amount of naked DNA introduced by lipid vesicles, process for their preparation and their use in the preparation of gene products
Gabay et al. Interaction of the lamB protein with the peptidoglycan layer in Escherichia coli K12
WO1996007756A1 (en) Decomposition of bacteria cells by phage lysins
CH640268A5 (en) Process for the preparation of filamentous hybrid phages, novel hybrid phages and their use
CH651317A5 (en) METHOD FOR ENZYMATIC SYNTHESIS OF DOUBLE-STRAND RNA, THIS METHOD, SYNTHETIZED DOUBLE-STRING RNA AND INTERFERON INDUCTORS CONTAINING THEM.
EP0316748B1 (en) Process for the selective cleavage of fusion proteins
DE4432053A1 (en) Use of Listeria bacteriophage coded lysine
DE3735379A1 (en) RNA POLYMERASE GENE, METHOD FOR THE PRODUCTION THEREOF AND MICROORGANISM WITH THIS GENE
DE3539702C2 (en)
DE2733273A1 (en) ENDONUCLEASEN AND METHOD OF MANUFACTURING IT
WO2002024904A2 (en) Method for producing ribonucleic acid (rna)
DE2930922C2 (en)
DE3527682C2 (en)
DE2645548C3 (en) Endonucleases and processes for their preparation
DE3108152C2 (en)
DE69633993T2 (en) Circular plasmids from Rhodococcus
DE19506615A1 (en) Detection of bacteria after lysis with phage lysin enzymes
DE3530218C2 (en)

Legal Events

Date Code Title Description
8122 Nonbinding interest in granting licenses declared
8139 Disposal/non-payment of the annual fee